Diabetics have been advised to carefully manage their medication and check their blood sugar levels as they fast during the holy month. The Health Ministry released an advisory on social media asking people living with the disease to stay alert throughout Ramadan to avoid any complications. They have also given general guidelines on how to use the various medications provided to control the condition but have urged patients to consult medical professionals especially if they have to inject insulin. Speaking to the GDN Royal Bahrain Hospital senior consultant in endocrinology and diabetes and Bahrain Diabetes and Endocrine Review chairman Dr Wiam Hussein explained the effects of fasting on those with diabetes. Insulin When done under medical approval and supervision fasting can help improve blood sugar control and insulin sensitivity he said. It can aid in weight loss which is of paramount importance in diabetes management. However it can also pose risks such as low blood sugar (hypoglycaemia) and high blood sugar (hyperglycaemia). Therefore it is imperative that diabetics consult with their healthcare providers before and during the fasting process. Dr Hussein recommend some practices that patients should observe in order to manage their blood-sugar level in Ramadan. Make sure to follow any changes your healthcare provider makes to medication specifically for the month he said. Regularly monitor blood sugar levels during fasting and after meals. This will help you better understand the changes that are happening in your body. He also highlighted the importance of maintaining a well-balanced diet during the holy month. Ensure you are eating a mix of proteins vegetables and carbohydrates he added. After breaking fast be mindful of sugary drinks and food. Avoid juices even fresh ones as they can cause a significant spike in sugar levels and drink unsweetened beverages. For dessert make sure they are low in sugar or just replace them with fruits as alternatives. Stay hydrated all night drink water and herbal tea over sugary drinks and caffeine. It is also important to stay physically active and engage in moderate activity in the non-fasting hours such as walking which helps improve blood sugar. According to the Health Ministry diabetes affects about 14.7 per cent of Bahrain s adult population and is expected to increase with a quarter of the population in the entire GCC suffering from the condition by 2030. Symptoms include the need to urinate often thirst constant hunger weight loss vision changes and fatigue. The GDN reported in January that medics were calling on people to undergo an urinalysis at least once a year as it could help in early detection of diabetes. It was estimated that about 40pc of cases lead to conditions such as kidney failure which is deadly if left untreated. Type 2 diabetes the most common form of diabetes is caused by several factors including lifestyle choices with obesity and physical inactivity a major concern. There are several antidiabetic medications used to treat the condition along with a proper diet and exercise programme and possibly with other medicines used to control high blood sugar or to increase the amount of insulin the pancreas makes. They include Glibenclamide Metformin Pioglitazone Hcl Vildaglipitin Empagliflozin and Liraglutide. People using Glibenclamide should use their regular dose for iftar but only half their dose for suhoor as it can cause a drop in blood-sugar level the ministry guidelines said. As for Metformin patients who take a 500mg pill once a day should take it just once with iftar. Those who take two pills a day should take one with iftar and one with suhoor. Those who take three pills a day should take two with iftar and one with suhoor and those who take four pills should take two each at iftar and suhoor. Patients on one dose of Gliclazide should take it once a day with iftar and people taking two doses should take one at iftar and one at suhoor. People taking Pioglitazone Hcl Vildaglipitin Empagliflozin or Liraglutide can take the same doses as they usually did prior to Ramadan.
Read More
Diabetics have been advised to carefully manage their medication and check their blood sugar levels as they fast during the holy month. The Health Ministry released an advisory on social media asking people living with the disease to stay alert throughout Ramadan to avoid any complications. They have also given general guidelines on how to use the various medications provided to control the condition but have urged patients to consult medical professionals especially if they have to inject insulin. Speaking to the GDN Royal Bahrain Hospital senior consultant in endocrinology and diabetes and Bahrain Diabetes and Endocrine Review chairman Dr Wiam Hussein explained the effects of fasting on those with diabetes. Insulin When done under medical approval and supervision fasting can help improve blood sugar control and insulin sensitivity he said. It can aid in weight loss which is of paramount importance in diabetes management. However it can also pose risks such as low blood sugar (hypoglycaemia) and high blood sugar (hyperglycaemia). Therefore it is imperative that diabetics consult with their healthcare providers before and during the fasting process. Dr Hussein recommend some practices that patients should observe in order to manage their blood-sugar level in Ramadan. Make sure to follow any changes your healthcare provider makes to medication specifically for the month he said. Regularly monitor blood sugar levels during fasting and after meals. This will help you better understand the changes that are happening in your body. He also highlighted the importance of maintaining a well-balanced diet during the holy month. Ensure you are eating a mix of proteins vegetables and carbohydrates he added. After breaking fast be mindful of sugary drinks and food. Avoid juices even fresh ones as they can cause a significant spike in sugar levels and drink unsweetened beverages. For dessert make sure they are low in sugar or just replace them with fruits as alternatives. Stay hydrated all night drink water and herbal tea over sugary drinks and caffeine. It is also important to stay physically active and engage in moderate activity in the non-fasting hours such as walking which helps improve blood sugar. According to the Health Ministry diabetes affects about 14.7 per cent of Bahrain s adult population and is expected to increase with a quarter of the population in the entire GCC suffering from the condition by 2030. Symptoms include the need to urinate often thirst constant hunger weight loss vision changes and fatigue. The GDN reported in January that medics were calling on people to undergo an urinalysis at least once a year as it could help in early detection of diabetes. It was estimated that about 40pc of cases lead to conditions such as kidney failure which is deadly if left untreated. Type 2 diabetes the most common form of diabetes is caused by several factors including lifestyle choices with obesity and physical inactivity a major concern. There are several antidiabetic medications used to treat the condition along with a proper diet and exercise programme and possibly with other medicines used to control high blood sugar or to increase the amount of insulin the pancreas makes. They include Glibenclamide Metformin Pioglitazone Hcl Vildaglipitin Empagliflozin and Liraglutide. People using Glibenclamide should use their regular dose for iftar but only half their dose for suhoor as it can cause a drop in blood-sugar level the ministry guidelines said. As for Metformin patients who take a 500mg pill once a day should take it just once with iftar. Those who take two pills a day should take one with iftar and one with suhoor. Those who take three pills a day should take two with iftar and one with suhoor and those who take four pills should take two each at iftar and suhoor. Patients on one dose of Gliclazide should take it once a day with iftar and people taking two doses should take one at iftar and one at suhoor. People taking Pioglitazone Hcl Vildaglipitin Empagliflozin or Liraglutide can take the same doses as they usually did prior to Ramadan.
Unlike breast cancer where public-based screening is available cervical cancer is the only gynaecological cancer offering the opportunity for early detection through routine screenings. This vital opportunity allows for early intervention when the cancer is still in its precancerous or initial stages. In contrast no effective screening methods exist for the early detection of other female genital tract cancers. However in the case of uterine cancer abnormal vaginal bleeding emerges as a common early-stage symptom providing a window for early diagnosis and the potential for a complete cure. Regrettably ovarian cancer lacks a reliable screening method or early warning symptoms. A significant portion of ovarian cancer cases (approximately two-thirds) are diagnosed in advanced stages making complete cure often unattainable. Nevertheless for patients experiencing non-specific symptoms such as bloating abdominal pain and tenderness which are common indicators of ovarian cancer consulting a physician may enhance the possibility of earlier diagnosis and treatment. Vulvar cancer ranks as the second least common cancer among female genital tract cancers following vaginal cancer. Early diagnosis is of paramount importance as survival rates significantly decrease when the disease spreads to the groin area. Vulvar cancer has two primary causes. The most common is HPV similar to cervical cancer with a precancerous stage. The other cause is underlying vulvar dystrophies which are more prevalent among elderly patients. C ommon symptoms of vulvar cancer include persistent itching burning or bleeding that does not respond to medical treatment. Additionally skin colour changes hypo or hyperpigmentation ulcers lumps or wart-like lesions while not specific require further evaluation especially if they persist. The inner and outer labia as well as the perineum are commonly affected sites. Due to the disease s location early detection is feasible but ignoring these symptoms and avoiding consultation with a physician may have dire consequences. In summary regular cervical cancer screenings and consulting a physician in cases of abnormal vaginal bleeding for uterine cancer (irregular periods in premenopausal patients or any bleeding in postmenopausal patients) or when experiencing the symptoms mentioned above for vulvar cancer offer the potential for early detection and improved chances of cure. On the other hand ovarian cancer often progresses insidiously and produces late symptoms. Nevertheless consulting a physician upon experiencing the symptoms described above may increase the likelihood of timely treatment. Patients with a strong family history of cancer should consider consulting an oncology specialist for genetic testing which can offer protection from cancer or early detection. Book an appointment with Royal Bahrain Hospital obstetrics and gynaecology consultant Dr Alpay Yilmaz 17246800 or WhatsApp 32181810.
Read More
Unlike breast cancer where public-based screening is available cervical cancer is the only gynaecological cancer offering the opportunity for early detection through routine screenings. This vital opportunity allows for early intervention when the cancer is still in its precancerous or initial stages. In contrast no effective screening methods exist for the early detection of other female genital tract cancers. However in the case of uterine cancer abnormal vaginal bleeding emerges as a common early-stage symptom providing a window for early diagnosis and the potential for a complete cure. Regrettably ovarian cancer lacks a reliable screening method or early warning symptoms. A significant portion of ovarian cancer cases (approximately two-thirds) are diagnosed in advanced stages making complete cure often unattainable. Nevertheless for patients experiencing non-specific symptoms such as bloating abdominal pain and tenderness which are common indicators of ovarian cancer consulting a physician may enhance the possibility of earlier diagnosis and treatment. Vulvar cancer ranks as the second least common cancer among female genital tract cancers following vaginal cancer. Early diagnosis is of paramount importance as survival rates significantly decrease when the disease spreads to the groin area. Vulvar cancer has two primary causes. The most common is HPV similar to cervical cancer with a precancerous stage. The other cause is underlying vulvar dystrophies which are more prevalent among elderly patients. C ommon symptoms of vulvar cancer include persistent itching burning or bleeding that does not respond to medical treatment. Additionally skin colour changes hypo or hyperpigmentation ulcers lumps or wart-like lesions while not specific require further evaluation especially if they persist. The inner and outer labia as well as the perineum are commonly affected sites. Due to the disease s location early detection is feasible but ignoring these symptoms and avoiding consultation with a physician may have dire consequences. In summary regular cervical cancer screenings and consulting a physician in cases of abnormal vaginal bleeding for uterine cancer (irregular periods in premenopausal patients or any bleeding in postmenopausal patients) or when experiencing the symptoms mentioned above for vulvar cancer offer the potential for early detection and improved chances of cure. On the other hand ovarian cancer often progresses insidiously and produces late symptoms. Nevertheless consulting a physician upon experiencing the symptoms described above may increase the likelihood of timely treatment. Patients with a strong family history of cancer should consider consulting an oncology specialist for genetic testing which can offer protection from cancer or early detection. Book an appointment with Royal Bahrain Hospital obstetrics and gynaecology consultant Dr Alpay Yilmaz 17246800 or WhatsApp 32181810.
Diabetics have been advised to carefully manage their medication and check their blood sugar levels as they fast during the holy month. The Health Ministry released an advisory on social media asking people living with the disease to stay alert throughout Ramadan to avoid any complications. They have also given general guidelines on how to use the various medications provided to control the condition but have urged patients to consult medical professionals especially if they have to inject insulin. Speaking to the GDN Royal Bahrain Hospital senior consultant in endocrinology and diabetes and Bahrain Diabetes and Endocrine Review chairman Dr Wiam Hussein explained the effects of fasting on those with diabetes. Insulin When done under medical approval and supervision fasting can help improve blood sugar control and insulin sensitivity he said. It can aid in weight loss which is of paramount importance in diabetes management. However it can also pose risks such as low blood sugar (hypoglycaemia) and high blood sugar (hyperglycaemia). Therefore it is imperative that diabetics consult with their healthcare providers before and during the fasting process. Dr Hussein recommend some practices that patients should observe in order to manage their blood-sugar level in Ramadan. Make sure to follow any changes your healthcare provider makes to medication specifically for the month he said. Regularly monitor blood sugar levels during fasting and after meals. This will help you better understand the changes that are happening in your body. He also highlighted the importance of maintaining a well-balanced diet during the holy month. Ensure you are eating a mix of proteins vegetables and carbohydrates he added. After breaking fast be mindful of sugary drinks and food. Avoid juices even fresh ones as they can cause a significant spike in sugar levels and drink unsweetened beverages. For dessert make sure they are low in sugar or just replace them with fruits as alternatives. Stay hydrated all night drink water and herbal tea over sugary drinks and caffeine. It is also important to stay physically active and engage in moderate activity in the non-fasting hours such as walking which helps improve blood sugar. According to the Health Ministry diabetes affects about 14.7 per cent of Bahrain s adult population and is expected to increase with a quarter of the population in the entire GCC suffering from the condition by 2030. Symptoms include the need to urinate often thirst constant hunger weight loss vision changes and fatigue. The GDN reported in January that medics were calling on people to undergo an urinalysis at least once a year as it could help in early detection of diabetes. It was estimated that about 40pc of cases lead to conditions such as kidney failure which is deadly if left untreated. Type 2 diabetes the most common form of diabetes is caused by several factors including lifestyle choices with obesity and physical inactivity a major concern. There are several antidiabetic medications used to treat the condition along with a proper diet and exercise programme and possibly with other medicines used to control high blood sugar or to increase the amount of insulin the pancreas makes. They include Glibenclamide Metformin Pioglitazone Hcl Vildaglipitin Empagliflozin and Liraglutide. People using Glibenclamide should use their regular dose for iftar but only half their dose for suhoor as it can cause a drop in blood-sugar level the ministry guidelines said. As for Metformin patients who take a 500mg pill once a day should take it just once with iftar. Those who take two pills a day should take one with iftar and one with suhoor. Those who take three pills a day should take two with iftar and one with suhoor and those who take four pills should take two each at iftar and suhoor. Patients on one dose of Gliclazide should take it once a day with iftar and people taking two doses should take one at iftar and one at suhoor. People taking Pioglitazone Hcl Vildaglipitin Empagliflozin or Liraglutide can take the same doses as they usually did prior to Ramadan.
Read More
Diabetics have been advised to carefully manage their medication and check their blood sugar levels as they fast during the holy month. The Health Ministry released an advisory on social media asking people living with the disease to stay alert throughout Ramadan to avoid any complications. They have also given general guidelines on how to use the various medications provided to control the condition but have urged patients to consult medical professionals especially if they have to inject insulin. Speaking to the GDN Royal Bahrain Hospital senior consultant in endocrinology and diabetes and Bahrain Diabetes and Endocrine Review chairman Dr Wiam Hussein explained the effects of fasting on those with diabetes. Insulin When done under medical approval and supervision fasting can help improve blood sugar control and insulin sensitivity he said. It can aid in weight loss which is of paramount importance in diabetes management. However it can also pose risks such as low blood sugar (hypoglycaemia) and high blood sugar (hyperglycaemia). Therefore it is imperative that diabetics consult with their healthcare providers before and during the fasting process. Dr Hussein recommend some practices that patients should observe in order to manage their blood-sugar level in Ramadan. Make sure to follow any changes your healthcare provider makes to medication specifically for the month he said. Regularly monitor blood sugar levels during fasting and after meals. This will help you better understand the changes that are happening in your body. He also highlighted the importance of maintaining a well-balanced diet during the holy month. Ensure you are eating a mix of proteins vegetables and carbohydrates he added. After breaking fast be mindful of sugary drinks and food. Avoid juices even fresh ones as they can cause a significant spike in sugar levels and drink unsweetened beverages. For dessert make sure they are low in sugar or just replace them with fruits as alternatives. Stay hydrated all night drink water and herbal tea over sugary drinks and caffeine. It is also important to stay physically active and engage in moderate activity in the non-fasting hours such as walking which helps improve blood sugar. According to the Health Ministry diabetes affects about 14.7 per cent of Bahrain s adult population and is expected to increase with a quarter of the population in the entire GCC suffering from the condition by 2030. Symptoms include the need to urinate often thirst constant hunger weight loss vision changes and fatigue. The GDN reported in January that medics were calling on people to undergo an urinalysis at least once a year as it could help in early detection of diabetes. It was estimated that about 40pc of cases lead to conditions such as kidney failure which is deadly if left untreated. Type 2 diabetes the most common form of diabetes is caused by several factors including lifestyle choices with obesity and physical inactivity a major concern. There are several antidiabetic medications used to treat the condition along with a proper diet and exercise programme and possibly with other medicines used to control high blood sugar or to increase the amount of insulin the pancreas makes. They include Glibenclamide Metformin Pioglitazone Hcl Vildaglipitin Empagliflozin and Liraglutide. People using Glibenclamide should use their regular dose for iftar but only half their dose for suhoor as it can cause a drop in blood-sugar level the ministry guidelines said. As for Metformin patients who take a 500mg pill once a day should take it just once with iftar. Those who take two pills a day should take one with iftar and one with suhoor. Those who take three pills a day should take two with iftar and one with suhoor and those who take four pills should take two each at iftar and suhoor. Patients on one dose of Gliclazide should take it once a day with iftar and people taking two doses should take one at iftar and one at suhoor. People taking Pioglitazone Hcl Vildaglipitin Empagliflozin or Liraglutide can take the same doses as they usually did prior to Ramadan.
Unlike breast cancer where public-based screening is available cervical cancer is the only gynaecological cancer offering the opportunity for early detection through routine screenings. This vital opportunity allows for early intervention when the cancer is still in its precancerous or initial stages. In contrast no effective screening methods exist for the early detection of other female genital tract cancers. However in the case of uterine cancer abnormal vaginal bleeding emerges as a common early-stage symptom providing a window for early diagnosis and the potential for a complete cure. Regrettably ovarian cancer lacks a reliable screening method or early warning symptoms. A significant portion of ovarian cancer cases (approximately two-thirds) are diagnosed in advanced stages making complete cure often unattainable. Nevertheless for patients experiencing non-specific symptoms such as bloating abdominal pain and tenderness which are common indicators of ovarian cancer consulting a physician may enhance the possibility of earlier diagnosis and treatment. Vulvar cancer ranks as the second least common cancer among female genital tract cancers following vaginal cancer. Early diagnosis is of paramount importance as survival rates significantly decrease when the disease spreads to the groin area. Vulvar cancer has two primary causes. The most common is HPV similar to cervical cancer with a precancerous stage. The other cause is underlying vulvar dystrophies which are more prevalent among elderly patients. C ommon symptoms of vulvar cancer include persistent itching burning or bleeding that does not respond to medical treatment. Additionally skin colour changes hypo or hyperpigmentation ulcers lumps or wart-like lesions while not specific require further evaluation especially if they persist. The inner and outer labia as well as the perineum are commonly affected sites. Due to the disease s location early detection is feasible but ignoring these symptoms and avoiding consultation with a physician may have dire consequences. In summary regular cervical cancer screenings and consulting a physician in cases of abnormal vaginal bleeding for uterine cancer (irregular periods in premenopausal patients or any bleeding in postmenopausal patients) or when experiencing the symptoms mentioned above for vulvar cancer offer the potential for early detection and improved chances of cure. On the other hand ovarian cancer often progresses insidiously and produces late symptoms. Nevertheless consulting a physician upon experiencing the symptoms described above may increase the likelihood of timely treatment. Patients with a strong family history of cancer should consider consulting an oncology specialist for genetic testing which can offer protection from cancer or early detection. Book an appointment with Royal Bahrain Hospital obstetrics and gynaecology consultant Dr Alpay Yilmaz 17246800 or WhatsApp 32181810.
Read More
Unlike breast cancer where public-based screening is available cervical cancer is the only gynaecological cancer offering the opportunity for early detection through routine screenings. This vital opportunity allows for early intervention when the cancer is still in its precancerous or initial stages. In contrast no effective screening methods exist for the early detection of other female genital tract cancers. However in the case of uterine cancer abnormal vaginal bleeding emerges as a common early-stage symptom providing a window for early diagnosis and the potential for a complete cure. Regrettably ovarian cancer lacks a reliable screening method or early warning symptoms. A significant portion of ovarian cancer cases (approximately two-thirds) are diagnosed in advanced stages making complete cure often unattainable. Nevertheless for patients experiencing non-specific symptoms such as bloating abdominal pain and tenderness which are common indicators of ovarian cancer consulting a physician may enhance the possibility of earlier diagnosis and treatment. Vulvar cancer ranks as the second least common cancer among female genital tract cancers following vaginal cancer. Early diagnosis is of paramount importance as survival rates significantly decrease when the disease spreads to the groin area. Vulvar cancer has two primary causes. The most common is HPV similar to cervical cancer with a precancerous stage. The other cause is underlying vulvar dystrophies which are more prevalent among elderly patients. C ommon symptoms of vulvar cancer include persistent itching burning or bleeding that does not respond to medical treatment. Additionally skin colour changes hypo or hyperpigmentation ulcers lumps or wart-like lesions while not specific require further evaluation especially if they persist. The inner and outer labia as well as the perineum are commonly affected sites. Due to the disease s location early detection is feasible but ignoring these symptoms and avoiding consultation with a physician may have dire consequences. In summary regular cervical cancer screenings and consulting a physician in cases of abnormal vaginal bleeding for uterine cancer (irregular periods in premenopausal patients or any bleeding in postmenopausal patients) or when experiencing the symptoms mentioned above for vulvar cancer offer the potential for early detection and improved chances of cure. On the other hand ovarian cancer often progresses insidiously and produces late symptoms. Nevertheless consulting a physician upon experiencing the symptoms described above may increase the likelihood of timely treatment. Patients with a strong family history of cancer should consider consulting an oncology specialist for genetic testing which can offer protection from cancer or early detection. Book an appointment with Royal Bahrain Hospital obstetrics and gynaecology consultant Dr Alpay Yilmaz 17246800 or WhatsApp 32181810.
No more news.
Amanat Holdings a leading healthcare and education company said that the Royal Hospital for Women & Children (RHWC) a new specialized healthcare facility has recently opened in Bahrain. Amanat acquired a 69.3 per cent stake in the hospital in August 2018 with a view to generating long-term sustainable value. Since acquisition Amanat has worked closely with its operating partners to secure top medical talent to deliver the highest standards of care with a focus on patient safety superior clinical outcomes and unparalleled patient experience a company statement said. Commencing with outpatient care at opening the hospital will ultimately offer an extensive range of medical services centred around women and children including maternity and neonatal care with NICU levels 1 2 and 3 assisted reproductive treatment (IVF) gynaecology paediatrics invasive and minimally invasive surgery and women-oriented wellness and aesthetic...
Read More
Amanat Holdings a leading healthcare and education company said that the Royal Hospital for Women & Children (RHWC) a new specialized healthcare facility has recently opened in Bahrain. Amanat acquired a 69.3 per cent stake in the hospital in August 2018 with a view to generating long-term sustainable value. Since acquisition Amanat has worked closely with its operating partners to secure top medical talent to deliver the highest standards of care with a focus on patient safety superior clinical outcomes and unparalleled patient experience a company statement said. Commencing with outpatient care at opening the hospital will ultimately offer an extensive range of medical services centred around women and children including maternity and neonatal care with NICU levels 1 2 and 3 assisted reproductive treatment (IVF) gynaecology paediatrics invasive and minimally invasive surgery and women-oriented wellness and aesthetic...
